A detailed history of Ameriflex Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ameriflex Group, Inc. holds 2,610 shares of ABT stock, worth $337,864. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,610
Previous 4,699 44.46%
Holding current value
$337,864
Previous $623 Million 44.03%
% of portfolio
0.18%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

SELL
$123.95 - $138.08 $258,931 - $288,449
-2,089 Reduced 44.46%
2,610 $349 Million
Q1 2025

May 15, 2025

BUY
$111.1 - $140.22 $15,776 - $19,911
142 Added 3.12%
4,699 $623 Million
Q4 2024

Feb 24, 2025

BUY
$111.93 - $119.39 $510,065 - $544,060
4,557 New
4,557 $583 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $227B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ameriflex Group, Inc. Portfolio

Follow Ameriflex Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriflex Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameriflex Group, Inc. with notifications on news.